ZYPREXA RELPREVV olanzapine (as pamoate monohydrate) 405mg powder for injection vial with diluent vial - medicine shortage information

Back to ALL shortages and discontinuations    Back to CRITICAL shortages and discontinuations

If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.

More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub

Product details Supply Impact Dates Further Details
ZYPREXA RELPREVV olanzapine (as pamoate monohydrate) 405mg powder for injection vial with diluent vial
AUST R: 143636
Active ingredients:
olanzapine pamoate monohydrate

Dosage form:
Injection, powder for

Sponsor:
Pharmaco Australia Ltd

Phone:
1800201564

From
05 Oct 2023
to
30 Nov 2024

Shortage status:
Current

Availability:
Limited Availability

Reason:
Transport / Logistic issues / Storage capacity issues

Management action:
The sponsor is working to expedite the next shipment.